FBLN1 and chronic obstructive pulmonary disease: In COPD, increased levels of FBLN1 are observed in patients and experimental models, with inhibiting FBLN1c reducing cigarette smoke-induced airway fibrosis, emphysema, and pulmonary inflammation [11].